Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis

Treatment of rheumatoid arthritis (RA) is aimed at long-term remission and inhibition of joint destruction by different biologic drugs. However, the choice of a particular biologic agent based on individual cases of RA remains unestablished. Interleukin-6 (IL-6) inhibitor and tumor necrosis factor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Shinya, Matsubara, Tsukasa, Fukuda, Koji, Funahashi, Keiko, Hashimoto, Marowa, Maeda, Toshihisa, Kamenaga, Tomoyuki, Takashima, Yoshinori, Matsumoto, Tomoyuki, Niikura, Takahiro, Kuroda, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538428/
https://www.ncbi.nlm.nih.gov/pubmed/33024253
http://dx.doi.org/10.1038/s41598-020-73968-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538428/
https://www.ncbi.nlm.nih.gov/pubmed/33024253
http://dx.doi.org/10.1038/s41598-020-73968-3

Ejemplares similares